Found 13 matching trials
Evaluating the Effectiveness of Boceprevir, Pegylated-Interferon Alfa 2b and Ribavirin in Treating Hepatitis C Virus (HCV) Infection in Adults With HIV and HCV Infection PHASE3 Hepatitis C virus (HCV) infection is a leading cause of death and illness i...
Show More Learn More & Join Trial
Impact of Physician Directed Education on Patient Compliance With Hepatitis C Therapy PHASE4 The purpose of this study is to evaluate the impact of a physician directed...
Show More Location
California Liver Institute
Learn More & Join Trial
Boceprevir/PegIFN α-2b/Riba in HCV+ Gt1 Menopausal Women, Nonresponders to PegIFN/Riba or Treatment-naives (MEN_BOC) PHASE3 The cohort of post-menopausal women represents a group of very-difficult-to...
Show More Location
Gastroenterology Unit
Learn More & Join Trial
Three-year Follow-up of Participants After Administration of Boceprevir or Narlaprevir for the Treatment of Chronic Hepatitis C (P05063) PHASE2 Study P05063 is a 3-year long-term follow-up (LTFU) study in participants p...
Show More Location
Multiple Locations
Learn More & Join Trial
A Pilot Study of Boceprevir for the Treatment of Genotype 6 HCV PHASE2 The purpose of this study is to evaluate the antiviral efficacy of Boceprev...
Show More Location
Box Hill Hospital
Learn More & Join Trial
Boceprevir in HIV-HCV Coinfected Patients Who Have Failed to a Previous Therapy With Peg-Interferon/Ribavirin PHASE2 The majority of Human immunodeficiency Virus (HIV)/Hepatitis C Virus (HCV) ...
Show More Location
CHU Sainte Marguerite
Learn More & Join Trial
Short Duration Versus Standard Response-Guided Therapy With Boceprevir Combined With PegIntron and Ribavirin in Previously Untreated Non-Cirrhotic Asian Participants With Chronic HCV Genotype 1 (MK-3034-107) PHASE3 The purpose of this study is to estimate the difference in the efficacy bet...
Show More Location
Multiple Locations
Learn More & Join Trial
An Observational Study on Dual And Triple Therapies Based on Peginterferon Alfa (e.g. Pegasys) in Patients With Chronic Hepatitis C N/A This prospective, multicenter, observational cohort study will evaluate the...
Show More Location
Multiple Locations
Learn More & Join Trial
Grazoprevir (MK-5172) Administered With Peginterferon and Ribavirin in Treatment-Naïve Participants With Chronic Hepatitis C (MK-5172-003) PHASE2 This study will evaluate the safety, tolerability, and antiviral activity o...
Show More Location
Multiple Locations
Learn More & Join Trial
Boceprevir in Subjects With Chronic Hepatitis C Genotype 1 Who Failed Prior Treatment With Peginterferon/Ribavirin (Study P05101AM3)(COMPLETED) PHASE3 This study involves treatment with boceprevir or placebo in combination wit...
Show More Location
Multiple Locations
Learn More & Join Trial